Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

26 Nov 2025 Evaluate
Zydus Lifesciences has enclosed a copy of press release dated November 26, 2025, titled ‘Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1907.80
Dr. Reddys Labs. 1377.65
Cipla 1402.60
Lupin 2007.65
Zydus Lifesciences 1207.80
View more..